5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
about
17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol productionClinical significance of estrogen receptor β in breast and prostate cancer from biological aspectsEstrogens in Male PhysiologyRoles of oestrogen receptors alpha and beta in behavioural neuroendocrinology: beyond Yin/YangFacilitation of male sexual behavior in Syrian hamsters by the combined action of dihydrotestosterone and testosterone.Estradiol induction of spermatogenesis is mediated via an estrogen receptor-{alpha} mechanism involving neuroendocrine activation of follicle-stimulating hormone secretionAndrogenic regulation of ventral epithelial bud number and pattern in mouse urogenital sinus.New knockout model confirms a role for androgen receptors in regulating anxiety-like behaviors and HPA response in mice.Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation.Androgens and estrogens in benign prostatic hyperplasia: past, present and future.Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats.The androgen metabolite, 5α-androstane-3β,17β-diol, decreases cytokine-induced cyclooxygenase-2, vascular cell adhesion molecule-1 expression, and P-glycoprotein expression in male human brain microvascular endothelial cells.The androgen metabolite, 5α-androstane-3β,17β-diol (3β-diol), activates the oxytocin promoter through an estrogen receptor-β pathway.Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells.The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistanceComprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityProfile of cell proliferation and apoptosis activated by the intrinsic and extrinsic pathways in the prostate of aging rats.Steroid Hormone Receptors as Potential Mediators of the Clinical Effects of Dutasteride: A Prospective, Randomized, Double-Blind Study.ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.Increased androgen receptor and remodeling in the prostatic stroma after the inhibition of 5-alpha reductase and aromatase in gerbil ventral prostate.Long-term inhibition of 5-alpha reductase and aromatase changes the cellular and extracellular compartments in gerbil ventral prostate at different postnatal ages.Mixtures of endocrine disrupting contaminants modelled on human high end exposures: an exploratory study in rats.Androgen receptor agonists increase lean mass, improve cardiopulmonary functions and extend survival in preclinical models of Duchenne muscular dystrophy.Effects of exposure to estradiol and estradiol plus testosterone on the Mongolian gerbil (Meriones unguiculatus) female prostate.Perinatal exposure to mixtures of anti-androgenic chemicals causes proliferative lesions in rat prostate.The anti-oestrogen fulvestrant (ICI 182,780) reduces the androgen receptor expression, ERK1/2 phosphorylation and cell proliferation in the rat ventral prostate.
P2860
Q27659972-85FC3FC7-1EE3-46FE-B6FC-480EB8881283Q28087001-BAAFF9CD-5ABD-4521-B294-17AEA586D04BQ30090708-73B7B425-9BB2-4545-880F-65897E90B5B4Q30439872-B845B60C-966B-4F31-9945-5882FBF0F6F4Q33697935-2C26EFFA-24AB-48F4-8600-0F0CE76029AEQ33874437-C28DEFA0-7110-4B36-81A0-E34DFA2F8D2CQ34583081-780125CB-7206-47EC-A7CD-1E134EC79877Q34972115-7C86D13F-CAEF-4BE9-8381-2E662EB017B6Q34976567-4C0EF188-DF13-4E91-AB3A-19DECAA76EB9Q35231660-63092397-31E7-44D7-9E9E-2AF0F039FD15Q35683915-9C4D49DF-4A01-4120-9146-5E95089593FBQ36439650-ABA82C15-3863-42B6-9187-532D882131E1Q36770994-37B8FC8C-3B53-464D-8F93-E1726D5892A5Q37078703-E87B5F97-0F64-4DCD-96EF-A131C87BA0F5Q37308154-024F4AAB-D1A3-461E-91AF-BFF004BD9D1EQ37582438-439D58F9-E154-4098-8A0D-89CB1BB4F516Q38704390-81C41AE6-693E-4ECB-8C06-68B365C3276FQ40311175-A8AF9F08-7CFD-49D8-BB5A-72A41D518429Q40918042-E1A9C68F-9A23-4939-9EF6-F93AF6A62D38Q44002372-1A45B2E1-F65B-4BBE-8413-01307B7F8EDCQ45782221-EA1C8A78-1CFE-4132-8E77-D485C026A390Q46196349-7299CC1E-9D52-4E4B-AEEB-EF8F37149756Q51029797-452A624B-2033-4738-A4AD-83AC7E49F66BQ51257742-E3EF1954-AE91-4E6B-B6DD-738A4B21AB99Q52654472-9F1CA8E3-AF40-4920-9D00-34F612F27F1AQ54647555-64C58FF8-647D-498E-BECF-DF8321D84DD1
P2860
5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@ast
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@en
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@nl
type
label
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@ast
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@en
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@nl
prefLabel
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@ast
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@en
5alpha-Androstane-3beta,17beta ...... ntral prostrate of adult rats.
@nl
P2093
P1433
P1476
5alpha-Androstane-3beta,17beta ...... entral prostrate of adult rats
@en
P2093
André G Oliveira
Cleida A Oliveira
Fernanda D Guedes
Polyanna H Coelho
Rex A Hess
P304
P356
10.1016/J.STEROIDS.2007.08.001
P50
P577
2007-08-09T00:00:00Z